List of articles with "Hengrui Pharma"

Hengrui at ESMO 2026

2026-10-29 07:22:15

Spain Madrid Hengrui Pharma oncology research ESMO 2026

Hengrui at ESMO 2026

2026-10-29 06:49:50

China Madrid Hengrui Pharma oncology research ESMO 2026

Hengrui at ESMO 2026

2026-10-29 06:49:13

China Shanghai Hengrui Pharma oncology research ESMO Congress 2026

Hengrui Oncology Innovations

2026-10-28 04:54:12

China Shanghai Hengrui Pharma oncology research ESMO Congress

Hengrui's Oncology Innovation

2026-10-28 03:48:36

China Madrid Hengrui Pharma oncology research ESMO 2026

Hengrui Pharma Growth

2026-10-27 10:11:55

China Shanghai Financial Growth Hengrui Pharma Innovative Drugs

Hengrui at ESMO 2026

2026-10-21 02:37:10

Spain Madrid Hengrui Pharma oncology research ESMO 2026

Hengrui Pharma at ESMO 2026

2026-10-21 02:36:58

Spain Madrid Hengrui Pharma oncology research ESMO 2026

Hengrui Pharma at ESMO 2026

2026-10-21 02:36:43

None Madrid oncology Hengrui Pharma ESMO Congress

Hengrui at ESMO 2026

2026-10-21 02:15:14

China Shanghai Hengrui Pharma ESMO 2026 Oncology Innovation

Hengrui at ESMO 2026

2026-10-20 08:21:14

Spain Madrid Hengrui Pharma oncology research ESMO Congress

Hengrui & Novo Partnership

2026-09-29 05:14:10

China Shanghai Novo Nordisk Hengrui Pharma HRS-1596

Hengrui Pharma Results

2026-08-19 11:58:15

China Shanghai financial results Hengrui Pharma Innovative Drugs

Hengrui's ASCO 2026 Highlights

2026-06-08 09:52:31

USA Chicago Hengrui Pharma oncology studies ASCO 2026

Hengrui at ASCO 2026

2026-06-01 05:55:24

China Chicago Hengrui Pharma oncology studies ASCO 2026

Hengrui & BMS Collaboration

2026-05-12 04:32:29

China Shanghai oncology Bristol Myers Squibb Hengrui Pharma

Positive Phase 2 Results

2026-05-11 13:52:50

USA San Francisco Hypertrophic Cardiomyopathy Hengrui Pharma Braveheart Bio

Hengrui Pharma Growth

2026-04-22 09:43:17

China Shanghai NASDAQ GLP-1 Hengrui Pharma

Phase 2 Results for HRS-1893

2026-03-30 14:04:29

None Hengrui Pharma Braveheart Bio HRS-1893

Hengrui Pharma Growth

2026-03-26 01:01:27

China Shanghai Hengrui Pharma global strategy Pharmaceutical IPO

Hengrui Pharma Q3 Growth

2025-10-27 11:38:10

China Shanghai Q3 2025 Hengrui Pharma oncology studies

Hengrui at ESMO 2025

2025-10-20 06:24:18

Germany Berlin Hengrui Pharma oncology research ESMO Congress

IDE849 Phase 1 Results

2025-09-07 16:16:18

USA IDEAYA Biosciences South San Francisco Hengrui Pharma IDE849

Hengrui-BH Bio Deal

2025-09-05 12:04:53

China Shanghai Hengrui Pharma Braveheart Bio HRS-1893

Hengrui and GSK Collaboration

2025-07-28 01:59:23

China Jiangsu GSK Hengrui Pharma inflammation

Hengrui Pharma at ASCO

2025-06-05 07:47:19

China Shanghai Hengrui Pharma ASCO 2025 Cancer Innovation

Trastuzumab Rezetecan

2025-05-29 09:32:12

China Shanghai Hengrui Pharma Trastuzumab HER2 Mutant

IDEAYA and Hengrui Collaboration

2024-12-29 11:06:35

United States South San Francisco IDEAYA Hengrui Pharma SHR-4849